Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
According to the latest research, the global Motion Sickness Treatment market size was valued at USD 581.49 million in 2022 and is expected to expand at a CAGR of 5.25% during the forecast period, reaching USD 790.6 million by 2028.
Motion sickness occurs when the brain receives conflicting information from the inner ear, eyes, and nerves in the joints and muscles. Motion Sickness often presents symptoms such as dizziness, nausea, cold sweats, and vomiting. Motion Sickness Treatment refers to products that provide the prevention or relief of motion sickness.
Impact of COVID-19
The outbreak of the new crown epidemic has had a significant impact on the Motion Sickness Treatment industry. On the supply side, due to the huge impact of the epidemic on Motion Sickness Treatment's supply chain, the interruption of pharmaceutical raw materials, and the increase in manufacturing and sales costs, the company's profitability has also been significantly affected. From the perspective of demand, the new crown pneumonia epidemic continues to have a huge impact on the global economy. Countries have adopted border controls and restricted the flow of people within their borders to varying degrees, and even adopted strict measures such as home isolation under special circumstances. In this context, the global tourism industry has generally been hit and suffered huge financial losses. According to data released by the United Nations World Tourism Organization, the new crown pneumonia epidemic has led to a significant reduction in the number of global tourists, and the global tourism revenue in 2020 will lose 1.3 trillion US dollars. In addition, under the influence of the epidemic, economic activity has slowed down, people are working from home, travel is restricted, and the demand for various means of transportation has decreased. Therefore, as the number of tourists decreases and people travel less, there is less demand for Motion Sickness Treatment in the market. In general, the impact of the new crown epidemic has limited the development of the industry.
Increased chance of developing motion sickness
In modern society, people's chances of developing motion sickness are increasing. First, with the continuous development of the transportation industry, people have more and more opportunities to use transportation, so the possibility of motion sickness is also increasing. For example, with economic development, many companies operate across countries or regions. Therefore, employees often need to travel long distances to conduct business. Therefore, the chance of developing motion sickness is increasing. In addition, motion sickness is not only related to transportation, but people who experience VR often experience motion sickness. The main reason for VR motion sickness is that the eyes of people using VR glasses transmit information to their brains, telling the brain to move around with changes in the environment, but the user's body is standing still or sitting. Motion sickness occurs at this time, which is a symptom of conflicting human body information. In addition, with the increase of income levels, more and more people go to amusement parks and other facilities to try various projects, and many game projects will also cause symptoms of motion sickness. In general, with the development of modern society, the chances of people developing motion sickness are increasing, therefore, the market demand for Motion Sickness Treatment is increasing.
Side Effects of Motion Sickness Drugs
At present, the drugs commonly used to relieve motion sickness mainly include dimenhydrinate, scopolamine, etc., and each drug has corresponding indications. Among them, two over-the-counter drugs, dimenhydrinate and scopolamine, are more common. The most common adverse reactions of dimenhydrinate include dullness, drowsiness, and inability to concentrate. Dimenhydrinate is contraindicated in patients allergic to ethanolamines and pregnant women, and should be used with caution in patients with asthma, glaucoma, and prostatic hypertrophy. Scopolamine may cause discomfort such as thirst, blurred vision, drowsiness, palpitations, facial flushing, and headache. Scopolamine is contraindicated in patients with glaucoma, enlarged prostate, myasthenia gravis, and severe heart disease. For the development of the industry, the side effects of Motion Sickness Drugs are one of the challenges facing the development of the industry.
Region Overview:
Geographically, North America held the largest market share – 46.41% in 2022.
Company Overview:
Prestige Brands is one of the major players operating in the Motion Sickness Treatment market, holding a share of 14.77% in 2023.
Prestige Brands
Prestige Consumer Healthcare Inc. is an American company that sells and distributes over-the-counter healthcare and household cleaning products. At Prestige Consumer Healthcare, the company focuses on product innovation and quality in the over-the-counter healthcare category. The company mainly focuses on digestive health, eyes, ears, nose and throat, oral care, pain relief and other areas.
Baxter International
Baxter International Inc., through its subsidiaries, provides a broad portfolio of essential healthcare products, including acute and chronic dialysistherapies; sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectablepharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostictechnologies; and respiratory health devices.
Segmentation Overview:
Among different product types, Antihistamines segment is anticipated to contribute the largest market share in 2028.
Anticholinergic
Anticholinergic exerts anti-motion sickness effects by reducing parasympathetic excitability.
Antihistamines
Antihistamines exert a powerful anti-motion sickness effect by acting on the vestibular and emesis centers, blocking the excitation of cholinergic synaptic labyrinthine impulses in the vestibular nucleus.
Application Overview:
In the Motion Sickness Treatment market, 41.67% of the total value was generated through the Hospitals segment by application in 2022.
This report elaborates on the market size, market characteristics, and market growth of the Motion Sickness Treatment industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Motion Sickness Treatment. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Motion Sickness Treatment Market Report Include:
Market Size Estimates: Motion Sickness Treatment market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Motion Sickness Treatment market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Motion Sickness Treatment market
Segment Market Analysis: Motion Sickness Treatment market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Motion Sickness Treatment market situations and prospects in major and top regions and countries
Motion Sickness Treatment Market
Motion Sickness Treatment Industry Chain: Motion Sickness Treatment market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Motion Sickness Treatment Industry News, Policies by regions
Motion Sickness Treatment Industry Porters Five Forces Analysis
Key players in the global Motion Sickness Treatment market are covered in Chapter 2:
Myungmoon Pharm
Baxter International
Klinge Pharma
Prestige Brands
Caleb Pharmaceuticals
Perrigo Company
Tong Ren Tang
WellSpring Pharmaceutical Corporation
GlaxoSmithKline
In Chapter 6 and Chapter 9, on the basis of types, the Motion Sickness Treatment market from 2018 to 2028 is primarily split into:
Anticholinergic
Antihistamines
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Motion Sickness Treatment market from 2018 to 2028 covers:
Hospitals
Clinics
Pharmacy
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Motion Sickness Treatment market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Motion Sickness Treatment industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Motion Sickness Treatment market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Motion Sickness Treatment industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Motion Sickness Treatment market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Motion Sickness Treatment market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Motion Sickness Treatment market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
2022
Motion sickness occurs when the brain receives conflicting information from the inner ear, eyes, and nerves in the joints and muscles. Motion Sickness often presents symptoms such as dizziness, nausea, cold sweats, and vomiting. Motion Sickness Treatment refers to products that provide the prevention or relief of motion sickness.
Impact of COVID-19
The outbreak of the new crown epidemic has had a significant impact on the Motion Sickness Treatment industry. On the supply side, due to the huge impact of the epidemic on Motion Sickness Treatment's supply chain, the interruption of pharmaceutical raw materials, and the increase in manufacturing and sales costs, the company's profitability has also been significantly affected. From the perspective of demand, the new crown pneumonia epidemic continues to have a huge impact on the global economy. Countries have adopted border controls and restricted the flow of people within their borders to varying degrees, and even adopted strict measures such as home isolation under special circumstances. In this context, the global tourism industry has generally been hit and suffered huge financial losses. According to data released by the United Nations World Tourism Organization, the new crown pneumonia epidemic has led to a significant reduction in the number of global tourists, and the global tourism revenue in 2020 will lose 1.3 trillion US dollars. In addition, under the influence of the epidemic, economic activity has slowed down, people are working from home, travel is restricted, and the demand for various means of transportation has decreased. Therefore, as the number of tourists decreases and people travel less, there is less demand for Motion Sickness Treatment in the market. In general, the impact of the new crown epidemic has limited the development of the industry.
Increased chance of developing motion sickness
In modern society, people's chances of developing motion sickness are increasing. First, with the continuous development of the transportation industry, people have more and more opportunities to use transportation, so the possibility of motion sickness is also increasing. For example, with economic development, many companies operate across countries or regions. Therefore, employees often need to travel long distances to conduct business. Therefore, the chance of developing motion sickness is increasing. In addition, motion sickness is not only related to transportation, but people who experience VR often experience motion sickness. The main reason for VR motion sickness is that the eyes of people using VR glasses transmit information to their brains, telling the brain to move around with changes in the environment, but the user's body is standing still or sitting. Motion sickness occurs at this time, which is a symptom of conflicting human body information. In addition, with the increase of income levels, more and more people go to amusement parks and other facilities to try various projects, and many game projects will also cause symptoms of motion sickness. In general, with the development of modern society, the chances of people developing motion sickness are increasing, therefore, the market demand for Motion Sickness Treatment is increasing.
Side Effects of Motion Sickness Drugs
At present, the drugs commonly used to relieve motion sickness mainly include dimenhydrinate, scopolamine, etc., and each drug has corresponding indications. Among them, two over-the-counter drugs, dimenhydrinate and scopolamine, are more common. The most common adverse reactions of dimenhydrinate include dullness, drowsiness, and inability to concentrate. Dimenhydrinate is contraindicated in patients allergic to ethanolamines and pregnant women, and should be used with caution in patients with asthma, glaucoma, and prostatic hypertrophy. Scopolamine may cause discomfort such as thirst, blurred vision, drowsiness, palpitations, facial flushing, and headache. Scopolamine is contraindicated in patients with glaucoma, enlarged prostate, myasthenia gravis, and severe heart disease. For the development of the industry, the side effects of Motion Sickness Drugs are one of the challenges facing the development of the industry.
Region Overview:
Geographically, North America held the largest market share – 46.41% in 2022.
Company Overview:
Prestige Brands is one of the major players operating in the Motion Sickness Treatment market, holding a share of 14.77% in 2023.
Prestige Brands
Prestige Consumer Healthcare Inc. is an American company that sells and distributes over-the-counter healthcare and household cleaning products. At Prestige Consumer Healthcare, the company focuses on product innovation and quality in the over-the-counter healthcare category. The company mainly focuses on digestive health, eyes, ears, nose and throat, oral care, pain relief and other areas.
Baxter International
Baxter International Inc., through its subsidiaries, provides a broad portfolio of essential healthcare products, including acute and chronic dialysistherapies; sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectablepharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostictechnologies; and respiratory health devices.
Segmentation Overview:
Among different product types, Antihistamines segment is anticipated to contribute the largest market share in 2028.
Anticholinergic
Anticholinergic exerts anti-motion sickness effects by reducing parasympathetic excitability.
Antihistamines
Antihistamines exert a powerful anti-motion sickness effect by acting on the vestibular and emesis centers, blocking the excitation of cholinergic synaptic labyrinthine impulses in the vestibular nucleus.
Application Overview:
In the Motion Sickness Treatment market, 41.67% of the total value was generated through the Hospitals segment by application in 2022.
This report elaborates on the market size, market characteristics, and market growth of the Motion Sickness Treatment industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Motion Sickness Treatment. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Motion Sickness Treatment Market Report Include:
Market Size Estimates: Motion Sickness Treatment market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Motion Sickness Treatment market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Motion Sickness Treatment market
Segment Market Analysis: Motion Sickness Treatment market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Motion Sickness Treatment market situations and prospects in major and top regions and countries
Motion Sickness Treatment Market
Competitive Landscape
and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.Motion Sickness Treatment Industry Chain: Motion Sickness Treatment market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Motion Sickness Treatment Industry News, Policies by regions
Motion Sickness Treatment Industry Porters Five Forces Analysis
Key players in the global Motion Sickness Treatment market are covered in Chapter 2:
Myungmoon Pharm
Baxter International
Klinge Pharma
Prestige Brands
Caleb Pharmaceuticals
Perrigo Company
Tong Ren Tang
WellSpring Pharmaceutical Corporation
GlaxoSmithKline
In Chapter 6 and Chapter 9, on the basis of types, the Motion Sickness Treatment market from 2018 to 2028 is primarily split into:
Anticholinergic
Antihistamines
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Motion Sickness Treatment market from 2018 to 2028 covers:
Hospitals
Clinics
Pharmacy
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Motion Sickness Treatment market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Motion Sickness Treatment industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Motion Sickness Treatment market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Motion Sickness Treatment industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Motion Sickness Treatment market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Motion Sickness Treatment market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Motion Sickness Treatment market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
